Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
12/2/2021
WuXi STA and Coherent Biopharma Forms Strategic Partnership
12/2/2021
SQZ Biotech Announces Acceptance by Roche Accelerator in China
12/2/2021
NHSA and MOHRSS Officially Issue the 2021 NRDL, Adding 74 and Removing...
12/1/2021
Financial-related Company News in Brief
12/1/2021
NMPA Issues Technical Guidelines Related to Companion Diagnostic Reag...
12/1/2021
Innovent and Ascentage Granted NMPA Approval for China's First 3rd Ge...
12/1/2021
Chinook Launches Chinese JV to Double Down on Kidney Disease R&D
12/1/2021
Genetron and AstraZeneca China Enter Co-Development Agreement for MR...
12/1/2021
Malaysia's IHH Healthcare Weighing Sale of Its $1B Chinese Hospital Bu...
12/1/2021
Novo Nordisk, Sanofi and Eli Lilly Cut Insulin Prices and Lose Share i...
11/30/2021
NMPA Issues the Dossier Requirements for Import and Export Permit of N...
11/30/2021
NMPA Announces Package Insert Revision of Glycerol Fructose and Sodium...
11/30/2021
JPO Releases Final Tender Outcome of the 6th VBP
11/30/2021
Jemincare Licenses Kras Inhibitor JMKX1899 to HUYABIO
11/30/2021
Clover Gets Another $36.9M from CEPI for Covid-19 Vaccine Development
11/30/2021
Changes in Notifiable Infectious Disease Incidence in China during the...
11/30/2021
Adagene Gains U.S. IND Approval for P1b/2 Trial of Anti-CTLA-4 mAb A...
11/30/2021
Nicholas Hall Reports Growth of Chinese OTC Dermatologicals Market in ...
11/30/2021
NH's DB6: Pandemic Continues to Dictate CHC Trends with China Recoveri...
11/30/2021
NiKang and Pfizer Ink Clinical Agreement over Novel Combo Therapies fo...
11/29/2021
GSK/ViiV Healthcare Files NDA for HIV Drug Cabotegravir in China
11/29/2021
PhIIC: Chinese Retail Pharmacy Market on Steady Growth 2019 - H1/2021
11/29/2021
NHSA Issues Three-Year Action Plan on DRD/DIP Payment System Reform (S...
11/29/2021
Clinical Value A Top Priority in Cancer Drug Trials, CDE Says (PharmaD...
11/26/2021
CDE Issued the Technical Requirements for Pharmaceutical Research of I...
11/26/2021
CDE Issues the Requirements for Pharmaceutical Study Common Questions ...
11/26/2021
CDE Solicits Comments the Guidelines for Evaluation of Immune-Related ...
11/26/2021
Nhwa Pharma Licenses China Rights of Lundbeck's Shelved Schizophrenia ...
11/26/2021
Luye Subsidiary Boan Bio Signs MOU with Merck to Build Next-Gen Digit...
11/26/2021
JPO Publicizes 6th VBP Tender Outcome, Which Slashes Insulin Prices by...
Page:
103
/
719
Total number of articles:
21546
:
[First]
[<<]
[101]
[102]
[103]
[104]
[105]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit